Physician

Julian Claus Fagerli, MD

According to 2025 Medicare claims, Julian Fagerli, MD (NPI: 1538148259) practices urology in the Charlottesville, VA market, with the plurality of this provider's patient population coming from Charlottesville City, VA. This provider's primary affiliated billing organization is UROLOGICAL ASSOCIATES, LTD (NPI: 1700810397; TIN: 540892025) and primary practice location at 22911-8607.

Fagerli's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 987 traditional Medicare patients, billed 14,567 HCPCS/CPT codes, and received $386,613 in Medicare payments. The top billing code was 99213 (Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more). Part D data shows 1,530 prescription claims across 423 beneficiaries totaling $796,024 in drug costs, led by Xtandi (Enzalutamide). DME data shows 79 claims. Open Payments data shows 75 records totaling $1,793. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $258,781 and ending at $796,024. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	711	14,591	$299,236
2016	733	14,231	$298,950
2017	754	18,833	$487,355
2018	734	20,094	$394,272
2019	784	14,825	$339,075
2020	871	13,237	$328,736
2021	991	16,023	$400,409
2022	1,042	13,137	$368,144
2023	1,094	17,483	$390,153
2024	987	14,567	$386,613

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	285	1,148	$258,781
2016	287	1,141	$121,841
2017	290	1,110	$137,606
2018	278	1,146	$278,718
2019	343	1,282	$499,401
2020	349	1,384	$377,769
2021	350	1,321	$207,459
2022	344	1,346	$128,349
2023	356	1,365	$327,110
2024	423	1,530	$796,024

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	11	$112
2018	N/R	17	$15,671
2019	N/R	61	$35,946
2020	N/R	56	$32,306
2021	N/R	51	$30,691
2022	N/R	85	$34,538
2023	11	82	$48,251
2024	N/R	79	$39,714

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	684	976	$65
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	386	442	$14
36415	Insertion of needle into vein for collection of blood sample	426	628	$9
51798	Ultrasound measurement of bladder capacity after voiding	693	1,025	$8
81001	Manual urinalysis test with examination using microscope, automated	878	1,483	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xtandi	Enzalutamide	50	1,500	$666,242
Myrbetriq	Mirabegron	78	4,800	$70,545
Gemtesa	Vibegron	19	1,110	$17,124
Mirabegron Er	Mirabegron	14	1,140	$12,144
Tamsulosin Hcl	Tamsulosin Hcl	505	42,046	$9,340

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4352	Intermittent urinary catheter; coude (curved) tip, with or without coating (teflon, silicone, silicone elastomeric, or hydrophilic, etc.), each	N	N/R	27	$34,401
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	N/R	21	$4,295
A4358	Urinary drainage bag, leg or abdomen, vinyl, with or without tube, with straps, each	N	N/R	18	$512
A4357	Bedside drainage bag, day or night, with or without anti-reflux device, with or without tube, each	N	N/R	13	$506

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	75	$1,793	Sumitomo Pharma America, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Julian Claus Fagerli, MD?

Tedicare shows public-source Medicare data for Julian Claus Fagerli, MD (NPI 1538148259), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Julian Claus Fagerli, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Julian Claus Fagerli, MD?

Julian Claus Fagerli, MD is linked to UROLOGICAL ASSOCIATES, LTD (billing NPI 1700810397) in the available physician profile data.

Does Julian Claus Fagerli, MD have Open Payments data?

Julian Claus Fagerli, MD has 75 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.